Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Jun. 30, 2018
Current assets :    
Cash $ 27,561 $ 48,440
Accounts receivable (net of allowance of $0 and $0, respectively) 16,548
Inventories 59,232 103,209
Other current assets 5,336 3,210
Total current assets 108,677 154,859
Total assets 108,677 154,859
Current liabilities:    
Accounts payable 197,653 215,782
Accrued expense-related party 185,974 197,974
Convertible notes payable - net of discount 954,099 633,870
Fair value of derivative liabilities 1,676,091 1,765,187
Short-term borrowings 400 1,000
Total current liabilities 3,014,217 2,813,813
Commitments and contingencies
Stockholders' deficit:    
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 44,013,396 issued and outstanding as of September 30, 2018 and 42,608,329 outstanding as of June 30, 2018, respectively) 44,013 42,608
Additional paid in capital 6,188,761 5,919,152
Accumulated deficit (9,138,313) (8,620,714)
Total stockholders' deficit (2,901,539) (2,658,954)
Total Liabilities and Stockholders' Deficit $ 108,677 $ 154,859